bluebird bio (BLUE) PT Lowered to $50 at Morgan Stanley
Tweet
Share
E-mailGet Alerts BLUE Hot Sheet
Price: $4.97 --0%
Rating Summary:
10 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 22
Rating Summary:
10 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 22
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison lowered the price target on bluebird bio (NASDAQ: BLUE) to $50.00 (from $68.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Streamex Corp. (STEX) PT Lowered to $4 at Needham
- Tango Therapeutics Inc. (TNGX) PT Raised to $68 at H.C. Wainwright
- Capricorn Metals Ltd (CMM:AU) PT Raised to AUD18.20 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
